Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Cardiovascular Imaging
Search: search_blue_button Advanced Search
Circulation: Cardiovascular Imaging. 2008;1:94-103
Published online before print July 30, 2008, doi: 10.1161/CIRCIMAGING.108.797449
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1/2/94    most recent
CIRCIMAGING.108.797449v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gyöngyösi, M.
Right arrow Articles by Glogar, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gyöngyösi, M.
Right arrow Articles by Glogar, D.
Related Collections
Right arrow Animal models of human disease
Right arrow Gene expression
Right arrow Nuclear cardiology and PET
Right arrow Acute myocardial infarction

Original Articles

Serial Noninvasive In Vivo Positron Emission Tomographic Tracking of Percutaneously Intramyocardially Injected Autologous Porcine Mesenchymal Stem Cells Modified for Transgene Reporter Gene Expression

Mariann Gyöngyösi, MD, PhD, FESC; Jeronimo Blanco, PhD; Teréz Marian, MD; Lajos Trón, MD; Örs Petneházy, PhD; Zsolt Petrasi, PhD; Rayyan Hemetsberger, MD; Julio Rodriguez, PhD; Gusztáv Font, VMD; Imre J. Pavo; István Kertész, MD; László Balkay, MD; Noemi Pavo, MSc; Aniko Posa, PhD; Miklos Emri, PhD; László Galuska, PhD; Dara L. Kraitchman, VMD, PhD; Johann Wojta, PhD; Kurt Huber, MD, FESC, FACC and Dietmar Glogar, MD, FESC

From the Department of Cardiology, Medical University of Vienna, Austria (M.G., R.H., I.J.P., N.P., A.P., J.W., D.G.); Centro de Investigación Cardiovascular (CSIC-ICCC), CIBER-BBN, Barcelona, Spain (J.B., J.R.); PET Centrum—Institute of Nuclear Medicine of the University of Debrecen, Hungary (T.M., L.T., I.K., L.B., M.E., L.G.); Institute of Diagnostic Imaging and Radiation Oncology, University of Kaposvar, Hungary (O.P., Z.P.); Downtown Animal Clinic, Budapest, Hungary (G.F.); The Johns Hopkins University, School of Medicine, Russell H. Morgan Department of Radiology and Radiological Science, Baltimore, MD (D.L.K.); 3rd Department of Medicine (Cardiology and Emergency Medicine), Wilhelminenhospital, Vienna, Austria (K.H.).

Correspondence to Mariann Gyöngyösi, MD, PhD, FESC, Department of Cardiology, Medical University of Vienna, Wahringer Gurtel 18–20, A-1090 Vienna, Austria, E-mail mariann.gyongyosi{at}meduniwien.ac.at

Received June 8, 2008; accepted July 18, 2008.

Background— Porcine bone marrow-derived mesenchymal stem cells (MSCs) were stably transfected with a lentiviral vector for transgene expression of the trifusion protein renilla luciferase, red fluorescent protein and herpes simplex truncated thymidine kinase (LV-RL-RFP-tTK; positron emission tomography [PET] reporter gene) for in vivo noninvasive tracking of the intramyocardially delivered MSC fate.

Methods and Results— A closed-chest, reperfused myocardial infarction was created in farm pigs. Sixteen days after myocardial infarction, LV-RL-RFP-tTK-MSCs were injected intramyocardially using electromechanical mapping guidance in the infarct border zone (n=7). PET-computed tomographic metabolic and perfusion imaging was performed after an intravenous injection of 10 mCi [18F]-FHBG and 13N-ammonia PET at 30±2 hours and 7 days after LV-RL-RFP-tTK-MSC treatment. Fusion imaging of the [18F]-FHBG PET-computed tomography with MRI was used to determine the myocardial location of the injected LV-RL-RFP-tTK-MSCs. Seven days after injections, [18F]-FHBG PET showed a decreased cardiac uptake with a mild increased pericardial and pleura uptake in the treated animals, which was confirmed by the measurement of luciferase activity. At 10 days, infarct size by MRI in the LV-RL-RFP-tTK-MSC-treated animals was smaller than controls (n=7) (23.3±1.5% versus 30.2±3.5%, P<0.005). The presence of the LV-RL-RFP-tTK-MSCs (5.8±1.1% of the injected cells) in the myocardium 10 days after intramyocardial delivery was confirmed histologically.

Conclusions— Reporter gene imaging enables the tracking of the persistence of viable LV-RL-RFP-tTK-MSC in the peri-infarcted porcine myocardium at 10 days after delivery using clinical PET scanners.

Key Words: cells • imaging • infarction • mapping • revascularization


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
JNMHome page
T. Higuchi, M. Anton, K. Dumler, S. Seidl, J. Pelisek, A. Saraste, A. Welling, F. Hofmann, R. A.J. Oostendorp, B. Gansbacher, et al.
Combined Reporter Gene PET and Iron Oxide MRI for Monitoring Survival and Localization of Transplanted Cells in the Rat Heart
J. Nucl. Med., July 1, 2009; 50(7): 1088 - 1094.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. L. Kraitchman and J. W.M. Bulte
In Vivo Imaging of Stem Cells and Beta Cells Using Direct Cell Labeling and Reporter Gene Methods
Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1025 - 1030.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
M. Nahrendorf, D. E. Sosnovik, B. A. French, F. K. Swirski, F. Bengel, M. M. Sadeghi, J. R. Lindner, J. C. Wu, D. L. Kraitchman, Z. A. Fayad, et al.
Multimodality Cardiovascular Molecular Imaging, Part II
Circ Cardiovasc Imaging, January 1, 2009; 2(1): 56 - 70.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. C. Wu
Molecular Imaging: Antidote to Cardiac Stem Cell Controversy
J. Am. Coll. Cardiol., November 11, 2008; 52(20): 1661 - 1664.
[Full Text] [PDF]